333

GENMONT BIOTECH INC

No trades
See on Supercharts
Market capitalization
‪1.76 B‬TWD
0.60TWD
‪32.99 M‬TWD
‪318.01 M‬TWD
‪80.52 M‬
Beta (1Y)
0.24

About GENMONT BIOTECH INC


CEO
Yu Chin Chen
Headquarters
Tainan
Founded
2000
ISIN
TW0003164000
FIGI
BBG000D1J038
Genmont Biotech Inc. engages in the research development, manufacturing, and selling of probiotic supplements. It operates through the GenMont and GenMont(China) segments. The company was founded on January 3, 2000 and is headquartered in Tainan, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 3164 is 20.25 TWD — it has decreased by −0.25% in the past 24 hours. Watch GENMONT BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange GENMONT BIOTECH INC stocks are traded under the ticker 3164.
3164 stock has risen by 0.99% compared to the previous week, the month change is a −7.71% fall, over the last year GENMONT BIOTECH INC has showed a −15.98% decrease.
3164 reached its all-time high on Jan 18, 2011 with the price of 113.20 TWD, and its all-time low was 16.20 TWD and was reached on Mar 23, 2020. View more price dynamics on 3164 chart.
See other stocks reaching their highest and lowest prices.
3164 stock is 1.74% volatile and has beta coefficient of 0.24. Track GENMONT BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is GENMONT BIOTECH INC there?
Today GENMONT BIOTECH INC has the market capitalization of ‪1.76 B‬, it has decreased by −0.98% over the last week.
Yes, you can track GENMONT BIOTECH INC financials in yearly and quarterly reports right on TradingView.
3164 net income for the last quarter is ‪5.74 M‬ TWD, while the quarter before that showed ‪14.67 M‬ TWD of net income which accounts for −60.88% change. Track more GENMONT BIOTECH INC financial stats to get the full picture.
GENMONT BIOTECH INC dividend yield was 2.02% in 2023, and payout ratio reached 130.96%. The year before the numbers were 2.95% and 106.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENMONT BIOTECH INC EBITDA is ‪117.24 M‬ TWD, and current EBITDA margin is 22.57%. See more stats in GENMONT BIOTECH INC financial statements.
Like other stocks, 3164 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENMONT BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENMONT BIOTECH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENMONT BIOTECH INC stock shows the sell signal. See more of GENMONT BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.